These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39322129)

  • 1. Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System.
    Ganguly K; Adhikary K; Acharjee A; Acharjee P; Trigun SK; Mutlaq AS; Ashique S; Yasmin S; Alshahrani AM; Ansari MY
    Int J Biol Macromol; 2024 Sep; 280(Pt 3):135967. PubMed ID: 39322129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMPs in learning and memory and neuropsychiatric disorders.
    Beroun A; Mitra S; Michaluk P; Pijet B; Stefaniuk M; Kaczmarek L
    Cell Mol Life Sci; 2019 Aug; 76(16):3207-3228. PubMed ID: 31172215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders.
    Kim YS; Joh TH
    Biomol Ther (Seoul); 2012 Mar; 20(2):133-43. PubMed ID: 24116286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of matrix metalloproteinases in regulating neuronal disorder.
    Mukherjee A; Swarnakar S
    Mol Biol Rep; 2015 Jan; 42(1):1-11. PubMed ID: 25374425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-3 in brain physiology and neurodegeneration.
    Lech AM; Wiera G; Mozrzymas JW
    Adv Clin Exp Med; 2019 Dec; 28(12):1717-1722. PubMed ID: 31851789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases and their inhibitors, modulators of neuro-immune interactions and of pathophysiological processes in the nervous system].
    Khrestchatisky M; Jourquin J; Ogier C; Charton G; Bernard A; Tremblay E; Rivera S
    J Soc Biol; 2003; 197(2):133-44. PubMed ID: 12910628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Metalloproteinases in the Plasticity of Excitatory and Inhibitory Synapses.
    Wiera G; Mozrzymas JW
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplays Between Matrix Metalloproteinases and Neurotropic Viruses: An Overview.
    Alghamdi SA; Alissa M; Alghamdi A; Alshehri MA; Albelasi A; Alzahrani KJ; Safhi AY
    Rev Med Virol; 2024 Nov; 34(6):e2585. PubMed ID: 39349731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets.
    Ethell IM; Ethell DW
    J Neurosci Res; 2007 Oct; 85(13):2813-23. PubMed ID: 17387691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
    Muri L; Leppert D; Grandgirard D; Leib SL
    Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
    Brkic M; Balusu S; Libert C; Vandenbroucke RE
    Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
    Van Hove I; Lemmens K; Van de Velde S; Verslegers M; Moons L
    J Neurochem; 2012 Oct; 123(2):203-16. PubMed ID: 22862420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloprotease activity shapes the magnitude of EPSPs and spike plasticity within the hippocampal CA3 network.
    Wójtowicz T; Mozrzymas JW
    Hippocampus; 2014 Feb; 24(2):135-53. PubMed ID: 24115249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMPs: a novel drug target for schizophrenia.
    Chopra K; Baveja A; Kuhad A
    Expert Opin Ther Targets; 2015 Jan; 19(1):77-85. PubMed ID: 25214056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
    Rosenberg GA
    Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted role of metalloproteinases in physiological and pathological conditions in embryonic and adult brains.
    De Stefano ME; Herrero MT
    Prog Neurobiol; 2017 Aug; 155():36-56. PubMed ID: 27530222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of matrix metalloproteinases in delayed cortical responses after stroke.
    Zhao BQ; Wang S; Kim HY; Storrie H; Rosen BR; Mooney DJ; Wang X; Lo EH
    Nat Med; 2006 Apr; 12(4):441-5. PubMed ID: 16565723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.